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 Unresolved anxiety can lead to some impact on which a person tends to have 
a negative assessment of the meaning of life, decreased quality of life, 
emotional changes such as chronic depression and psychosis disorders.  
The general objective in this research is to find out the symptoms of anxiety 
symptoms of chronic kidney disease patients undergo hemodialysis.  
This research employed cross sectional design. This study used non-
probability sampling type quota sampling. Sample was calculated using the 
Slovin formula obtained a sample size of 171. The proportion of patient with 
chronic kidney disease treated with hemodialysis based on the anxiety level 
resulting mild anxiety (86.5%) and moderate anxiety (13.5%). There are 
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Anxiety is a disorder that is triggered by the existence of a clear situation or object (from outside  
the individual itself), which actually does no harm. Unresolved anxiety can lead to some impact on which  
a person tends to have a negative assessment of the meaning of life, decreased quality of life, emotional 
changes such as chronic depression and psychosis disorders [1-3]. The 2013 Baseline Health Research data 
shows the prevalence of mental emotional disorders demonstrated by symptoms of depression and anxiety for 
the age above 15 years reaching around 14 million people or 6% of the total population of Indonesia. Severe 
mental disorders, such as schizophrenia reach approximately 400,000 people or as many as 1.7 per 1,000 
population [4-6]. 
Chronic kidney disease (CKD) is a growing public health problem. The incidence of chronic kidney 
disease in many countries is 200 cases per one million populations per year. The results of a systematic 
review and meta-analysis conducted by Hill et al, 2016, obtained a global prevalence of CKD amounted 
13.4%, in Indonesia, treatment of kidney disease received second largest financing from the Health Social 
Security Administration Agency after heart disease [7-9]. CKD is a clinical condition characterized by 
irreversible decrease of renal function, so that at certain degree it will require replacement therapy for kidney 
function that is either hemodialysis or kidney transplantation. Criteria for CKD are kidney damage that 
occurs more than 3 months, in the form of structural or functional abnormalities, with or without a decrease 
in glomerular filtration rate (GFR). CKD may also occur when the GFR value is less than 60mL/min/1.73m2 
which lasts for as long as more than 3 months, with or without kidney damage [10, 11]. 
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CKD is already a public health problem. Various attempts were made to overcome various problems 
of chronic kidney disease such as regulating diet, dialysis and kidney transplantation. The stages of CKD are 
based on the remaining kidney physiology that can be measured by creatinine clearance. At stage V chronic 
kidney disease with creatinine clearance tests showing less than 15mL/min/1.73m2, it is recommended  
to undergo hemodialysis therapy [11-13]. 
Hemodialysis is a procedure in where blood is released from the patient's body and circulates in  
a machine outside the body called dialyzer. Hemodialysis uses the diffusion principles of dissolved 
substances through the semi permeable membrane [14]. In patients with CKD who undergo hemodialysis 
will experience psychological pressure after undergoing hemodialysis therapy. Psychological pressure that 
occurs in the form of anxiety, insomnia, difficulty concentrating, no appetite, feeling hopelessly exaggerated, 
and loss of life spirit. Psychological pressure occurs because in patients undergoing hemodialysis is very 
dependent on the appliance, if the patient with CKD is not undergoing therapy it will be a threat of a dead 
verdict that is left to wait for time. In Luana NA's research entitled Anxiety in Chronic Kidney Disease 
Patients Underwent Hemodialysis at the Indonesian Christian University Hospital in 2013 showed that based 
on HDRS scores it was known that most (77.8%) respondents had anxiety disorders in varying degrees.  
A total of 29.6% of hemodialysis patients suffer from mild anxiety disorders, and 27.8% of subjects suffer 
from severe anxiety disorders [15, 16]. 
 
 
2. RESEARCH METHOD 
This research was descriptive quantitative study with where data retrieval is only taken one time to 
find out the proportion of anxiety levels of CKD patients undergoing hemodialysis therapy at the Rasyida 
Kidney Speciality Hospital, Medan, Indonesia in January 2020. Data collection was carried out using beck 
anxiety inventory (BAI) questionnaire. BAI questionnaire will be given to patients and asked to answer the 
questionnaire that has been provided with interview. This study uses a sampling method that is non-
probability sampling type quota sampling, calculated using the Slovin formula obtained sample size  
of 171 patients. In this study the data collected is in the form of primary data. Primary data collected 
included: Data on anxiety levels of CKD patients at Rasyida Kidney Speciality Hospital. 
 
 
3. RESULTS  
3.1.  Result based on gender 
The results of research in patients with CKD undergoing hemodialysis at the Rasyida Kidney 
Speciality Hospital obtained the proportion of gender based on the level of anxiety of the respondents.  
Table 1 shows the anxiety level based on the gender proportions in patient with CKD undergoing with 
hemodialysis in Rasyida Kidney Speciality Hospital, resulting men with mild anxiety (60.2%) women with 
mild anxiety (26.3%), men with moderate anxiety (11.1%) and women with moderate anxiety (2.3%). 
 
 
Table 1. Proportion of gender 
Gender 
Mild anxiety Moderate anxiety Severe anxiety Total 
n % n % n % n % 
Men 103 60.2 19 11.1 0 0 122 71.3 
Women 45 26.3 4 2.3 0 0 49 28.7 
Total 148 86.5 23 13.5 0 0 171 100.0 
 
 
3.2.  Result based on age 
The results of research in patients with CKD undergoing hemodialysis at the Rasyida Kidney 
Special Hospital obtained the proportion of age based on anxiety levels. Table 2 shows that the proportion of 
age based on the anxiety level in patients with CKD undergoing hemodialysis at the Rasyida Kidney Special 
Hospital, resulting patients with mild anxiety levels were mostly found in the age range 41-50 years, as many 
as 71 patients (41.5%) and followed by an age range of 31-40 years as many as 32 patients (18.7%). Patients 
with moderate anxiety levels were also mostly found in the age range 41-50 years, as many as 11 patients 
(6.4%) and followed by an age range of 31-40 years, as many as five patients (2.9%). 
 
3.3.  Result based frequency 
Table 3 shows that the proportion of length of undergoing hemodialysis based on the level of 
anxiety among patients. The table describes that patients with a mild level of anxiety were most often found 
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in the duration of hemodialysis >1-3 years as many as 49 patients (28.7%) and followed by duration of 
hemodialysis >3-5 years as many as 38 patients (22.2%). For patients with moderate levels of anxiety were 
mostly found in the duration of hemodialysis >1-3 years, as many as 8 patients (4.7%) and followed by those 
who had been on hemodialysis >3-5 years and >5-7 years, as many as 5 patients (2.9%). 
 
 
Table 2. Proportion of age 
Age 
(years) 
Mild anxiety Moderate anxiety Severe anxiety Total 
 n % n % n % n % 
20-30 7 4.1 2 1.2 0 0 9 5.3 
31-40 32 18.7 5 2.9 0 0 37 21.6 
41-50 71 41.5 11 6.4 0 0 82 48.0 
51-60 21 12.3 1 0.6 0 0 22 12.9 
61-70 14 8.2 3 1.8 0 0 17 9.9 
71-80 3 1.8 1 0.6 0 0 4 2.3 
Total 148 86.5 23 13.5 0 0 171 100.0 
 
 
Table 3. Proportion of frequency 
Frequency 
(length of hemodialysis) 
Mild anxiety Moderate anxiety Severe anxiety Total 
n % n % n % n % 
1-12 month 19 11.1 4 2.3 0 0 23 13.5 
>1-3 years 49 28.7 8 4.7 0 0 57 33.3 
>3-5 years 38 22.2 5 2.9 0 0 43 25.1 
>5-7 years 30 17.5 5 2.9 0 0 35 20.5 
>7-9 years 12 7.0 1 0.6 0 0 13 7.6 
Total 148 86.5 23 13.5 0 0 171 100.0 
 
 
3.4.  Description of anxiety symptoms in patient with CKD 
Table 4 shows that majority of patient are in the mild anxiety (86.5%).   
 
 
Table 4. Description of anxiety symptoms in patient with CKD 
Anxiety level n % 
Mild 148 86.5 
Moderate 23 13.5 




Anxiety is a disorder that is triggered by the existence of a clear situation or object. Unresolved anxiety 
can cause several impacts including; decreased quality of life, emotional changes such as chronic depression and 
psychotic disorders. CKD is a clinical condition characterized by a decrease of renal function so that a certain 
degree will require kidney function replacement therapy such as hemodialysis. Hemodialysis is a procedure where 
bloods is removed from the patient’s body and circulate in a machine outside the body called dialyzer [1, 14, 17]. 
Hemodialysis uses the diffusion principles of dissolved substances through the semi permeable 
membrane. The results of a systematic review and meta-analysis conducted by Hill et al, 2016, found a global 
prevalence of CKD of 13.4%. In patients with CKD who undergo hemodialysis will experience psychological 
stress in the form of: anxiety, insomnia, difficulty concentrating, no appetite, feeling excessive despair, and loss of 
life spirit. Psychological pressure occurs because in patients who undergo hemodialysis is very dependent on the 
appliance, if patients with CKD not undergoing the therapy, it will be a threat of a dead verdict that is left waiting 
for time [9, 18, 19].
 
Based on the results of univariate research and analysis which amounted to 171 respondents showed that 
the proportion of gender based on anxiety level of CKD patients dominated by male, include 103 men (60.2%) and 
45 women (26.3%) sufferers with mild anxiety, 19 men (11.1%) and 4 women (2.3%) with moderate anxiety. The 
results of this study are in line with the research of Riselligia Caninsti in Central Jakarta stating that subjects with 
anxiety levels classified as abnormal borderline amounted 7 people, which is about 23.3% with more men than 
women. While the subject with a normal anxiety classified 22 people, which was around 73.33%, with a total of 14 
men and 8 women [20, 21]. Evidence suggests that mental health services have historically ignored the needs of 
female patients. In the central nervous system, estrogen can alter the concentration and availability of 
neurotransmitters such as serotonin and noradrenalin, as well as estrogen increases bonding from GABA agonist 
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and up-regulated GABA receptors to change in depression; this induced estrogen can be a natural anti-depressant 
(neuroprotective) in women [22, 23]. Results of the proportion of age based on the anxiety level of patients with 
CKD, dominated by patients aged 41-50 years with mild anxiety as many as 71 people (41.5%), and followed by 
ages 31-40 years with 32 people mild anxiety (18.7%). Prospective studies suggest that anxiety disorders are 
chronic, i.e., patients may suffer from their disorder for years or decades. However, this does not mean that an 
anxiety disorder lasts permanently for the rest of the patient’s life. Anxiety disorders start in childhood, 
adolescence, or early adulthood until they reach a peak in middle age, then tending to decrease again with older 
age. The median age of onset for anxiety disorders is 11 years [24, 25]. 
The results of this study showed that the proportion of the length of time undergoing hemodialysis in 
CKD patients was that of patients who had the most hemodialysis for >1-3 years amounted 49 people (28.7%) with 
mild anxiety. The minimum duration for most of the anxiety disorders is >6 months, and the intensity is deemed to 
be disproportionate to the actual level of threat. Anxiety can be a diagnostic symptom in other psychiatric 
disorders, including depression, post-traumatic stress disorder (PTSD), and obsessive compulsive disorder, among 
others. Women experience pathologic anxiety at a rate approximately twice that of men. The length of undergoing 
hemodialysis of a CKD patient can be influenced by previous illnesses which can result in further complications, 
as well as experiencing a decrease in body function causing the patient in his daily life, so that the problem can 
cause the patient to experience anxiety. Respondents who have long undergone hemodialysis tend to have a lighter 
level of anxiety compared to respondents who have recently undergone hemodialysis. This is because due to the 
length of time someone undergoes hemodialysis, a person will be more adaptive to the dialysis unit. Previous study 
found the length of undergoing hemodialysis with anxiety levels obtained an r value of 0.22; this result shows a 
very low correlation between the length of undergoing hemodialysis and anxiety [19, 26, 27].
  
Depression and anxiety are considered to be the most common end-stage renal disease-related 
psychological disorders, with higher prevalence and incidence rates in this population than those  
in the general population. In study by de Brito et al., the prevalence rates of symptoms of depression and anxiety 
among patients undergoing dialysis were 31.2% and 27.9%, respectively, among the overall sample studied. 
Furthermore, depression affected approximately three times more dialysis patients than transplantation patients, 
whereas anxiety affected 1.5-times more dialysis patients. Anxiety refers to persistent, excessive, and unrealistic 
worry about everyday events or things such as financial crises, domestic issues, health care problems, and worrying 
about the future. Anxiety disorders are the most prevalent mental disorders that pose immense healthcare costs and 
a high burden of disease. Study by Dziubek et al., revealed that nearly 68% of respondents in Dialysis Patients had 
symptoms of depression. Apart from depression, patients also struggled with anxiety disorders. Elevated levels of 
anxiety were observed in approximately 50% of patients [28-30].  
The limitations of researchers in conducting research on the description of anxiety symptoms in CKD 
patients undergoing hemodialysis therapy at the Rasyida Kidney Specialty Hospital are researchers not aware of any 
other contributing factors of anxiety. These factors are such as family support, socio-economic factors, co morbidities, 




The majority of patients with CKD undergoing hemodialysis at the Rasyida Kidney Special Hospital 
were in mild anxiety (86.5%). The anxiety level based on the gender proportions in patients with CKD undergoing 
with hemodialysis in Rasyida Kidney Speciality Hospital, resulting men with mild anxiety (60.2%). The anxiety 
level based on the age proportions in patients with CKD undergoing hemodialysis at the Rasyida Kidney Special 
Hospital, resulting patients at the age of 41-50 years old with mild anxiety (41.5%). The proportion of length of 
undergoing hemodialysis based on the level of anxiety in patients with CKD who undergoing hemodialysis at the 
Rasyida Kidney Special Hospital, resulting mild anxiety over long period of hemodialysis >1-3 years (28.7%). 
Researchers are expected to find any other contributing factors of anxiety such as family support,  
socio-economic factors, co morbidities that may be the cause of anxiety in patients with CKD undergoing 
hemodialysis therapy. Researchers are expecting to other clinicians to be able to provide education about 
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